glp 1 for diabetes type 2 GLP-1 receptor agonists are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 and Inflammation: How These

doi: 10.1111/dom.13494 81 JungSYKimJSChoiIYLeeGHKimYHKangJHet al

For Research Use Only not for human or animal consumption

Watch for: Unusual injection site reactions (excessive redness, swelling, pain, or injection site reactions beyond normal ) Gastrointestinal symptoms that seem disproportionate to your dose ( unexpected diarrhea , severe nausea, headaches ) Signs of inadequate blood sugar control (for diabetes patients) Allergic-type reactions (hives, difficulty breathing, rapid heartbeat) Most people who use recently expired tirzepatide experience nothing more than slightly reduced effectiveness

10.3389/fnmol.2021.697440 Front